8TH INTERNATIONAL ADRENAL CANCER SYMPOSIUM

PROGRAMMA DIDATTICO

MODULO 1
Capitolo	1	Venturing through transcriptional and epigenetic lands of adrenocortical tumors Antonio Lerario, Michigan University
Capitolo 2		DNA-based markers as a window on intratumor heterogeneity Guillaume Assié, Cochin Hospital
Capitolo 3		Cellular senescence in adrenal homeostasis and cancer Katie Basham, Huntsman Cancer Institute, University Utah
Capitolo 4		Liquid biopsy in the assessment of adrenocortical carcinoma heterogeneity: where are we now? Peter Igaz, Semmelweis University
MODULO 2
Capitolo 1		PRC2 stabilizes a differentiated cell state required for sustained proliferation in ACC Dipika Mohan, Michigan University
Capitolo 2		Combined inactivation of ZNRF3 and TP53 alter the immune microenvironment and favor ACC development Pierre Val, French National Centre for Scientific Research
Capitolo 3		Adrenocortical carcinoma xenograft in zebrafish embryos as a model to study in vivo cytotoxicity of molecular target agents Sandra Sigala, University of Brescia
Capitolo 4		How to treat ACC by targeting lipid metabolism and ferroptosis Matthias Kroiss, University of Munich
Capitolo 5		Targeting cytoskeleton dynamics against metastatic dissemination in ACC Enzo Lalli, French Institute of Health and Medical Research
Capitolo 6		Keynote lecture Translating the results of preclinical research to clinics Gary Hammer, Michigan University
Capitolo 7		Proffered papers on preclinical studies in ACC Andrea Abate, Nour Abou Nader, Kleiton Silva Borges, Christina Bothou, Giulia Cantini, Rosa Catalano, Mark S. Cohen, Justine Cristante, Soha Reda El Sayed, Elisa Rossini, Carmen Ruggiero, Mariangela Tamburello, Luciana Chain Veronez
MODULO 3
Capitolo 1		Laparoscopic surgery for all, for some, or for none? Francesco Porpiglia, University of Turin
Capitolo 2		Why R0 resection is not attained in all patients? Jeff Lee, MD Anderson Cancer Center
Capitolo 3		Surgery in metastatic adrenocortical carcinoma: when and why? Electron Kebebew, Stanford University
Capitolo 4		Hyperthermic intraperitoneal chemotherapy and conversion surgery: rationale and results Guido Tiberio, University of Brescia
MODULO 4
Capitolo 1		How the Adiuvo trial may change clinical practice Massimo Terzolo, University of Turin
Capitolo 2		Predictive factors of adjuvant mitotane therapy Isabelle Bourdeau, CHUM Research Center
Capitolo 3		Adjuvant chemotherapy: is it worth a try? Otilia Kimpel, Wurzburg University
Capitolo 4		Adjuvant radiotherapy: new life in an old concept Tobias Else, Michigan University
Capitolo 5		Keynote lecture: Medical treatment for ACC: a critical view on the past, present and future Martin Fassnacht, Wurzburg University
Capitolo 6		Proffered papers on preclinical studies in ACC Gamze Akkus, Barbara Altieri, Anna Calabrese, Anne Jouinot, Marina Koulenti, Laura Sophie Landwehr, Juliane Lippert, Panagiotis Mourelatos, Laury Nicolas, Stéfanie Parisien – La Salle, Jonathan Poirier, Soraya Puglisi, Victor Sgrougi, Rebecca V. Steenaard, Antonio Stigliano, Nada Younes, Vanessa Zambelli
MODULO 5
Capitolo 1		Glucocorticoids, microenvironment and potential therapeutic implication Silviu Sbiera, Würzburg University
Capitolo 2		How bad is cortisol excess for patients with adrenal tumors? Irina Bancos, Mayo Clinic
Capitolo 3		Osilodrostat: a new player in the field Antoine Tabarin, University of Bordeaux
Capitolo 4		Detection and management of mitotane induced hypoadrenalism Rossella Libè, Cochin Hospital
MODULO 6
Capitolo 1		Prognostic factors and their impact on practice Cristina Ronchi, University of Birmingham
Capitolo 2		What is oligometastatic ACC? And how to treat it? Julien Hadoux, Charles Roux, Gustave Roussy Institute
Capitolo 3		New markers and end-points to assess tumor response Eric Baudin, Matthieu Faron, Gustave Roussy Institute
Capitolo 4		Management of advanced adrenocortical cancer in children Raul C. Ribeiro, St. Jude Children’s Research Hospital
MODULO 7
Capitolo 1		How to exploit preclinical models in the search of new drugs Constanze Hantel, University Hospital of Zurich
Capitolo 2		Next-generation molecular target therapies for adrenocortical carcinoma Joakim Crona, Uppsala University
Capitolo 3		Is immunotherapy a game changer? Mouhammed Habra, MD Anderson Cancer Center
MODULO 8
Capitolo 1		Do we know all on unwanted effects of mitotane? Deborah Cosentini, University of Brescia Soraya Puglisi, University of Turin
Capitolo 2		A patient journey in the disease Giampiero Mazzaglia, University of Milano Bicocca
Capitolo 3		Role of patient reported outcomes Rebecca Steenaard, Maxima Medical Center
Capitolo 4		Emesis management and supportive care in advanced ACC receiving chemotherapy plus mitotane Alfredo Berruti, University of Brescia
Capitolo 5		Keynote lecture Challenges in designing randomized clinical studies in rare diseases Paolo Bruzzi, University of Genoa

È OBBLIGATORIO:

Rispondere positivamente ad almeno il 75% della prova di verifica dell'apprendimento
Compilare la scheda di valutazione dell’evento FAD
Compilare il questionario di soddisfazione
Scaricare l’attestato relativo ai crediti ECM

Mozilla Firefox	https://support.mozilla.org/it/kb/Gestione%20dei%20cookie
Google Chrome	https://support.google.com/chrome/answer/95647?hl=it
Internet Explorer	http://windows.microsoft.com/it-it/windows-vista/block-or-allow-cookies
Safari 6/7 Mavericks	https://support.apple.com/kb/PH17191?viewlocale=it_IT&locale=it_IT
Safari 8 Yosemite	https://support.apple.com/kb/PH19214?viewlocale=it_IT&locale=it_IT
Safari su iPhone, iPad, o iPod touch	https://support.apple.com/it-it/HT201265

PROGRAMMA DIDATTICO

CON LA SPONSORIZZAZIONE NON CONDIZIONANTE DI

provider ecm e segreteria organizzativa

Uso dei cookie

Tipologie di Cookie

Cookie tecnici

Cookie analitici

Cookie di analisi di servizi di terze parti

Cookie per integrare prodotti e funzioni di software di terze parti

Cookie di profilazione

Siti Web e servizi di terze parti

Informazioni sui cookie

__utmz

__utmc

__utmb

__utma

__utmt

PHPSESSID

Come disabilitare i cookie mediante configurazione del browser